About Careers MedBlog Contact us
Medindia LOGIN REGISTER
Advertisement

Personalized Therapy With Dalcetrapib Improves Outcomes for Cardiovascular Disease

by Dr. Trupti Shirole on January 15, 2015 at 12:30 AM
Font : A-A+

 Personalized Therapy With Dalcetrapib Improves Outcomes for Cardiovascular Disease

A new personalized therapy with dalcetrapib for cardiovascular disease has been demonstrated by researchers at the Montreal Heart Institute.

The research team analyzed 5749 patients who received dalcetrapib or placebo and provided DNA in a clinical study. They found a strong association between the effects of dalcetrapib and a specific gene called ADCY9 (adenylate cyclase 9) on chromosome 16, particularly for a specific genetic variant (rs1967309).

Advertisement

In patients with the genetic profile AA at rs1967309, there was a 39 percent reduction in combined clinical outcomes including heart attacks, strokes, unstable angina, coronary revascularizations and cardiovascular deaths with dalcetrapib compared to placebo. From a second study it was seen that patients with the favorable genetic profile also benefited from reduction in the amount of atherosclerosis (thickened walls) of their carotid artery walls with dalcetrapib.

Lead investigator Jean-Claude Tardif said, "These results will lead to a genetics-guided clinical study in patients with the appropriate genetic background to allow review by health regulatory agencies and to provide personalized therapy with dalcetrapib. It also offers great hope for precision treatments for patients with cardiovascular diseases and for curbing atherosclerosis, the first cause of mortality in the world. "

This discovery may pave the way for a new era in cardiovascular medicine, with personalized or precision drugs. The study appears in the Journal Circulation Cardiovascular Genetics.

Source: Medindia
Advertisement
Advertisement
Advertisement

Recommended Reading

This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close
×

Personalized Therapy With Dalcetrapib Improves Outcomes for Cardiovascular Disease Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests